tinuing stimulation by TSH may eventually lead to thyroid neoplasia. Equivocal results have been reported in different studies on the genotoxic potential of ATZ (EHC, 1994) . However, 3-mercapto-1,2,4-triazole (MTZ: CAS No. 3179-31-5) also has a common fundamental structure with AMT, and was demonstrated to have stronger antithyroid activity than ATZ (Takaoka et al., 1994) . These 1,2,4-triazole derivatives including 3-nitro-1,2,4-triazole (NTZ: CAS No. 24807-55-4) were shown to inhibit thyroid peroxidase in vitro and in vivo in a competitive manner. Structural formulas of AMT and these allied substances were shown in Fig. 1 .
A variety of other chemicals are already known to have an antithyroid effect. These chemicals are mainly classi--ides (such as thiourea, thiouracil, propylthiouracil, methimazole, carbimazole, and goitrin), (2) aniline derivatives and related compounds (e.g., sulfonamides, paraaminobenzoic acid, paraaminosalicylic acid, and amphenone) and (3) substituted phenols (such as resorcinol, phloroglucinol, and 2,4-dihydroxybenzoic acid) (Capen, 2008) . The thioamides generally have more potent activity than other groups. Based on an in vitro analytical study of the inhibition of isolated thyroid peroxidase, two mechanisms by some thioamides were characterized as reversible inhibition in case of ethylenethiourea and N,N,N',N'-tetramethylthiourea (Doerge and Takazawa, 1990; Freyberger and Ahr, 2006) and irreversible inactivation (mechanismbased, suicide inhibition) of propylthiouracil and 2-mercaptobenzimidazole (Davidson et al., 1978; Doerge, 1986) . However, when propylthiouracil was administered to rats, it seemed that only the reversible mechanism is active (Davidson et al., 1978; Taurog and Dorris, 1989) . Anyhow, many thioamides are known to induce thyroid neoplasia by long-term exposure to rats (IARC, 2001) .
In case of AMT, there are amino and mercapto groups in the single triazole structure, suggesting that each may indicate an independent clear antithyroid action, respectively, and the 3rd and 5th positions in the triazole are considered to be equivalent, because the double bonds within the triazole are in a resonance state. Therefore, it is very interesting how the strength of the jointantithyroid actions by amino and mercapto groups in triazole is -ence on the reproductive parameters in the multi-generation study at a dose of 100 mg/kg/day which induced hyperplasia of the thyroid in all animals (Gaines et al., 1973) . ATZ also demonstrated no treatment-related effect in a teratology study up to 1,000 mg/kg/day. Therefore, it is presumed that serious reproductive or developmental toxicity is not expected with AMT.
This article reports the results of repeated-dose and reproductive/developmental toxicity of AMT in rats by the OECD Test Guideline No. 422 (OECD, 1996) in compliance with Good Laboratory Practice. As a result, clear hypothyroidism was shown as predicted but the intensity was much lower than the expected. Including with the relevant information, the mechanism of AMT-induced hypothyroidism was discussed that it may be different from that of structural similar analogs such as other triazoles and thioamides.
MATERIALS AND METHODS
This study was conducted in compliance with OECD guideline No. 422, "Combined Repeated-dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test" (OECD, 1996) at the Chemicals Evaluation and Research Institute, Japan (CERI, Oita, Japan). All procedures complied with the OECD Principles for Good Laboratory Practice (GLP, November 26, 1997) . Animals were treated in compliance with the applicable animal welfare regulations [Declaration of Helsinki (2000) and Guideline for animal experiments at CERI, Hita according to the LABORATORY ANIMAL SCIENCE (1987) by the American Association for Laboratory Animal Science].
by infrared spectroscopy (IR) before and after this study. The AMT was suspended in a 5.0 w/v% gum arabic solution prepared from gum Arabic (Wako Pure Chemical Pharmaceutical Corporation, Fukuoka, Japan), and administered to the animals by oral gavage. To control rats the vehicle alone was administered. The daily application volume (4 ml/kg body weight) was based on the latest measured body weight.
Before the start of the study, the AMT in the 0.025 and -neous dispersion and stable for 5 days in a dark and cool place using high performance liquid chromatography (HPLC). Dosing solutions were prepared once every three or four days and stored in a dark and cool place. The concentrations of dosing formulations were analyzed at the first preparation by HPLC, and confirmed to be within 100 ± 10% of each nominal concentration.
Experimental design
To 12 males and 12 females AMT was daily administered by gavage at 0 (control), 10, 50 and 250 mg/kg/ day. The dose levels were determined based on the results and three females were given AMT at 0, 25, 250, 500 and 1,000 mg/kg/day for 14 days. Two males died at 1,000 mg/kg/day. Enlargement of the thyroid gland, and hypertrophy and hyperplasia of follicular epithelial cells were observed in males and females at 250 mg/kg/day and above. Hypertrophy of hepatocytes, centrilobular and prominent nucleoli of centrilobular hepatocytes in the liver, anisonucleosis and prominent nucleoli of the tubular epithelium in of the kidneys were found in both sexes at 500 mg/kg/day and above. Therefore, the doses were set at 0, 10, 50 and 250 mg/kg/day for the main study.
To males AMT was administered for 42 days beginning from 14 days before mating. On the day after the final administration, 7 of 12 rats in the 0 and 250 mg/kg/day groups and all in the 10 and 50 mg/kg/day groups were administration period, five males in the 0 and 250 mg/ kg/day groups were reared for 14 days without treatment as the recovery group. To females AMT was administered for 42-48 days beginning from 14 days before mating to day 4 of lactation throughout the mating and geseach in the 0 and 250 mg/kg/day groups were administered without mating for 42 days and reared for the fol--ing was designated as day 1 of administration and the day
Observation and examination Repeated-dose toxicity
During the administration period, animals were observed twice a day for general appearance. During the recovery period, observation was performed once a day. Detailed clinical observations, such as ease of removal from the cage, handling observation and behavior in the arena, were performed once a week for males, and once a week in weeks 1-5 and on the day before necropsy (postpartum day 4) for females. In males, functional observaan automated grip strength meter MATYS, Toyo Sangyo, Toyama, Japan) and locomotor activity count (with a rat activity monitoring system, ACTIMO-10, SHINTECHNO, Fukuoka, Japan), were conducted in five rats of each as follow: optic, pinna, pain, papillary and air righting close day, were examined in each group on the day before necropsy (postnatal day 4). In the 0 and 250 mg/kg/day recovery groups of males, grip strength and locomotor activity count were examined in recovery week 2, because -tion week 6.
Body weights were measured on days 1, 3, 7, 14, 21, 28, 35 and 42 in males. Body weight of females were measured on days 1, 3, 7 and 14 in the pre-mating period, days 0, 7, 14, 17 and 20 in the gestation period and days 0 and 4 in the lactation period. In the recovery period, measurement of body weight was performed on days 1, 3, 7 and 14 in males and females.
Food consumption was measured on days 1, 3, 7, 14, 21, 28, 35 and 42 in males. Females were measured on days 1, 3, 7 and 14 in the pre-mating period, days 0, 7, 14, 17 and 20 in the gestation period and days 0 and 4 in the lactation period. In the recovery period, measurement of food consumption was performed on days 1, 3, 7 and 14 in males and females.
At the termination of the administration and recovper group from the abdominal aorta after overnight fasting under ether anesthesia. Some samples were treated with ethylenediaminetetraacetic acid dipotassium (EDTA-2K) and examined for hematological analysis such as red blood cell count, hemoglobin concentration, hematocrit, mean corpuscular volume (MCV), the mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), white blood cell count, and platelet count by CELL-DYN3500 (Abbott laboratories, Abbott Park, IL, USA). Reticulocyte count and differential white blood cell count were analyzed with ADVIA120 (Siemens, Munich, Germany). Prothrombin time (PT) and activated partial thromboplastin time (APTT) were measured using plasma separated from another part of the sample treated with 3.2% sodium citrate with KC-10A (Amelung, Lemgo, Germany). Serum or plasma prepared from the other blood samples were analyzed for aspartate aminotransferase (AST), alanine aminotransferase (ALT), cholinesterase (ChE), total protein, albumin, albumin/globulin ratio, and total bilirubin using 7150 Clinical analyzer (Hitachi High-Tech, Tokyo, Japan).
urea nitrogen (BUN), creatinine, calcium (Ca), and inorganic phosphorus (IP) were measured by 7170 Clinical analyzer (Hitachi High-Tech). Sodium (Na), potassium Kanagawa, Japan). At the termination of administration and recovery periUrine was collected for 15-17 hr in a metabolic cage, and was examined for urine volume, color, turbidity, specific gravity, pH, protein, glucose, occult blood and urinary sediment. Specific gravity and urinary sediment were measured by SPR-N (Atago, Tokyo, Japan) and BH2 (Olympus, Tokyo, Japan), respectively. All animals were sacrificed by bleeding from the abdominal aorta under ether anesthesia on the day after recovery period (recovery group), and the external surface, all orifices, subcutis, cranial, thoracic, abdominal and pelvic cavities and their components were then examined macroscopically. The brain, pituitary gland, thyroid, thymus, heart, liver, spleen, kidneys, adrenals, testes and epididymides were removed and weighed. The trachea, lungs, stomach, intestines, urinary bladder, prostate, seminal vesicles, ovaries, uterus, vagina, spinal cord, sciatic nerve, bone marrow (femur), axillar lymph nodes and mesenteric lymph nodes were also collected. The testes -ative, and the other organs and tissues with 10% neutralized formaldehyde solution. In the 0 and 250 mg/kg/day groups, all organs and tissues were sectioned, stained with hematoxylin-eosin and examined histopathologically under a light microscope. The 10 and 50 mg/kg/day and recovery groups were examined if treatment-related changes were observed in the 250 mg/kg/day group.
Reproductive/developmental toxicity
For each female, the estrous cycle was examined by day when successful mating was demonstrated.
In the main group, each female was moved and reared in a cage cohabitated with a male of the same dose group at night until successful copulation occurred or 2 weeks later. The presence of sperm in the vaginal smear and/ or a vaginal plug was considered as evidence of mating, and the day of successful mating was designed as day 0 of gestation. The pregnant females were allowed to deliver spontaneously and nurse their pups. If dams built a nest by 15:00, the day was determined as day 0 of lactation or postnatal day 0. In addition, the number of corpora lutea on the ovaries and the implantation sites in the uterus were counted at necropsy. The pairing days until copulation, copulation, fertilization, conception and implantation indices, pre/post-implantation loss, delivery dams and delivery indices were calculated in each dose group.
The number of pups born, stillborns, live pups at birth and live pups at the end of observation, sex ratio of pups born and live pups, and external abnormality of live pups were examined on postnatal day 0. In addition, the general appearance and number of live pups were noted once daily by postnatal day 4. In each pup, the body weight was measured on postnatal days 0 and 4.
Statistical analysis
Body weight, food consumption, grip strength, locomotor activity count, hematological and blood chemical estrous cycle length, pairing days until copulation, gestation length, number of corpora lutea, implantation sites, pups born, stillborns, live pups at birth and live pups at the end of observation, sex ratios of pups born and live pups on postnatal days 0 and 4, sex ratio of live pups on postnatal day 4 and pups' weights on postnatal days 0 and 4 were analyzed by the Bartlett's test for homogenenot found, one-way analysis of variance was performed.
way analysis of variance, the values in the 0 mg/kg/day group and each dose group were analyzed by Dunnett's --lyzed by the nonparametric Dunnett's test.
The numbers of feces and urine pools were analyzed -metric Dunnett's test.
Abnormal estrous cyclicity ratio, copulation, fertilization, conception and delivery dam indices, and sex ratios Vol. 38 No. 5 of live pups at birth and on postnatal days 0 and 4 were analyzed by Fisher's exact test.
The implantation index, pre/post-implantation loss, delivery index, external abnormality pups ratio, delivery index and viability indices on postnatal days 0 and 4 were examined by the Kruskal-Wallis test.
RESULTS

General appearance and functional observations
No deaths occurred in males. White turbid urine and salivation right after administration were observed in all males in the 250 mg/kg/day group. Soft stools were also found in 8 of 12 males in the 250 mg/kg/day group. Three females in the 250 mg/kg/day group died during late gestation, and white turbid urine and salivation were transiently observed in the 250 mg/kg/day group. No othadministration and recovery periods on daily clinical observations and detailed observations. For the functional observations, there were no treatment-related changes in all groups of both sexes (data not shown).
Body weight and food consumption
The body weights of males and females in the 250 mg/kg/day group were lower than those of the con--cantly low value was only found at 35 days after the start -cant differences between the control and each experimental group in both sexes including the recovery groups.
tion was found in males in the 250 mg/kg/day group on administration days 14 and 28, in females in the 50 mg/ kg/day group on administration days 7 and in the 250 mg/kg/day group on administration days 7 and 14. There -tion in other periods and/or other group (data not shown).
Hematological examination
Hematological analysis data shows that AMT obviously induces anemia in both sexes (Table 1) . In males and females, red blood cell count, hemoglobin concentration and hematocrit value were decreased by 10-20% and the MCV and MCHC were increased by 10% at 250 mg/kg/day compared to the controls. These changes were -es were not considered to be a treatment-related effect because they were within the range of background data and/or not dose-related.
Blood chemical examination
Among 19 parameters examined at the end of admin- Vol. 38 No. 5 males or females were statistically significantly different from the controls. However, these were not considered to be due to an adverse effect of AMT because all of them were within the range of the background data and/ or not dose-related, except the increase in total cholesterol in 250 mg/kg/day males (70% of the control) (date not shown).
Urinalysis
There were no treatment-related changes in all groups of both sexes (data not shown).
Organ weights
In males, there were no critical changes in the absolute organ weights but the relative organ weights of the liver and thyroid glands in the 250 mg/kg/day group were stacontrol, respectively, in the main study (Tables 2 and 3 ). These changes recovered to the normal level after the recovery period. In females, the absolute and relative organ weights of the thyroid glands in the 250 mg/kg/day -tive organ weights of the liver were noted. Additionally, the relative kidney weight in 250 mg/kg/day females was the recovery period, compared to the controls.
Full histopathological examination was conducted and test substance are summarized in Table 4 .
In males, follicular cell hypertrophy of the thyroid glands was observed in 60% of animals at 50 mg/kg/ day and vacuolization, hypertrophy and decreased eosinophilic granules of the cells in the anterior pituitary glands were observed in all animals at 250 mg/kg/day. Hypertrophy of centrilobular hepatocytes was also noted in all animals at 250 mg/kg/day. In kidneys at 250 mg/kg/ day, increases in the eosinophilic bodies and hyaline drop2u -globulin rests of the thyroid gland and solitary cysts in the medulla and a subcapsular solitary cyst of the kidney were incidental because they were found spontaneously and at a low incidence.
In females, follicular cell hypertrophy of the thyroid glands was observed at 250 mg/kg/day without any changes in the anterior pituitary gland and liver. In kidneys, vacuolization of the tubular epithelium with or without regenerative epithelium was found in one of five females at 10 mg/kg/day, four of six females at 50 mg/kg/day and three of twelve females at 250 mg/kg/ day. The renal changes in one female at 10 mg/kg/day were judged to have occurred due to incidental bad health, and not to be caused by the administration of AMT, because extremely low food intake during the lactation period, emaciation, atrophy of the thymus and hypertrophy of the squamous epithelium in the forestomach, etc. observed as bad health markers were not found in females in the higher dose groups. An increase in extramedullary hematopoiesis in the liver and spleen was found in one and three of twelve animals, respectively, at 250 mg/ kg/day. In three females found dead on day 23 of gestation, the main changes were perforation or necrosis of the fundic mucosa in the forestomach or glandular stomach, adrenal cortex hypertrophy, and vacuolization of the tubular epithelium with regenerative epithelium.
After the recovery period, there were no treatment-related changes in any organs at 250 mg/kg/day.
Reproductive/Developmental toxicity mean estrous cycle length or cyclicity in any groups (data not shown). Reproductive/developmental parameters are described in Table 5 . The number of mated pairs, copulated pairs and pregnant females, including the related indices were not affected by AMT administration. Three pregnant females at 250 mg/kg/day died on gestation day 23 without delivery and one pregnant female at 250 mg/ -tation day 25. Therefore, the post-implantation loss ([(Number of implantation sites -Number of live pups at birth) /Number of implantation sites] × 100) at 250 mg/ kg/day was dramatically increased as almost 5-fold the control, although it is not statistically significant. Two females at 250 mg/kg/day delivered only one and two pups, respectively, and all pups died in postpartum day 0. Entire litter was loss during postpartum day 1 to 3 was observed in each one of the control, 50 and 250 mg/kg/ day females due to abandonment of pups. Two females at 50 mg/kg/day were infertile, but no histopathological abnormalities were found in any reproductive organs. In the 250 mg/kg/day group, the gestation length was sta--nificant changes were found in the number of corpora lutea or implantation sites. On the other hand, the delivery dam index (number of pups born/number of implantation sites) and the number of pups born were statistically the control. Due to this decreased number of pups born, 114.2 ± 9.5
123.7 ± 13.6
Reticulocyte (%) 6.7 ± 2.7 6.5 ± 3.3 6.6 ± 2. the number of live pups at birth and the birth index were respectively, of the control. However, there were no statistically significant changes in the sex ratio and pups' weights on postpartum day 0 and postpartum day 4, and no external anomalies of the pups.
DISCUSSION
The most expected effect of AMT was considered to be toxicity of the thyroid glands, because two antithyroidal structures are present within a single molecule, the triazole derivative. In fact, the relative thyroid weight 250 mg/kg/day and hypertrophy of thyroid follicular cells was observed in males at 50 and 250 mg/kg/day and in females at 250 mg/kg/day. Hypertrophy or vacuolization of the anterior pituitary glands was also found in males at 250 mg/kg/day. However, we recognized that AMT at a dose of 250 mg/kg/day, even for longer than 42 days of administration, has an unexpectedly small effect on the relative weight of the thyroid gland such as 1.3-and 1.4-fold that of males and females, respectively, in the control group. On the other hand, 2-mercaptobenzimidazole (CAS No. 583-39-1), known as a strong antithyroid chemical, induced a 12.6-and 11.2-fold increase in the relative thyroid weight of males and females, respectively, at 50 mg/kg/day in the 28-day repeated-dose oral toxicity study compared to the control (Kawasaki et al., 1998) . Propylthiouracil (CAS No. 51-52-5) induced a 2.8-fold increase in the relative thyroid weight of males at the very low dose of 1.0 mg/kg/day in the 28-day oral study (Yamasaki et al., 2002) . A weak thyrotoxic substance, ethylenethiourea/2-imizolidinethione even induced 1.9-and 1.6-fold increases in the relative thyroid weight in males and females, respectively, at 30 mg/kg/day in the 28 days oral study (MHLW, 2004) compared to the control. ATZ (2.8-fold increase in the relative thyroid thyroid weight in males at 126 mg/kg/day for 7 days compared to the control) and MTZ (2.7-fold increase in the relative thyroid weight of males at 152 mg/ kg/day for 7 days) (Takaoka et al., 1994) , which are both structural analogs of AMT, showed a remarkably stronger effect than AMT. Structural formulas of these and below reference substances were shown in Fig. 1 .
This unexpectedly weak antithyroid effect of AMT may suggest that two active sites in a single molecule must interfere mutually, leading to much lower thyrotoxicity. In fact, there are some cases of chemicals with multiple active sites that did not induce such active toxicity. For example, antithyroid activity was not recognized with 1, 3, 4, 6(1H, 3H, (MHLW, 2007a) , which consists of only three thiourea molecules. In the toxicity test report, there is no mention of hypertrophy or relative weight of the thyroid glands, indicating that there were at least no obvious macroscopic changes in the thyroid glands. As another example, thiosemicarbazide , which consists of a hydrazine moiety (possible hemolytic anemia) and thiourea (possible thyrotoxicity), induced convulsions, but neither anemia nor thyrotoxicity (Parks et al., 1952) .
Another histopathological change caused by AMT was hypertrophy of the centrilobular hepatocytes with an increase in the relative liver weight. In males at the high dose of 250 mg/kg/day the relative weights of the liver 27% and 30%, respectively, compared to the control, and in females at the high dose of 250 mg/kg/day the relative weights of the liver and thyroid were increased by 10% and 42%, respectively, compared to the control. A similar relationship as that of AMT has been reported for at least three chemicals, namely, 3,5-xylidine (CAS No. 108-69-0), dicyclopentan-1-ylsilanediol (CAS No. 211495-85-1) and 4-methyl-2,4-diphenylpent-1-ene (CAS No. 6362-80-7). As for 3,5-xylidine, in males at the high dose of 360 mg/kg/day the relative weights of the liver and thyroid gland were increased by 29% and 49%, respectively, compared to the control, and in females at the high dose of 360 mg/kg/day the relative weights of the liver and thyroid gland were increased by 37% and 40%, respectively, compared to the control (MHLW, 1997) . In case of dicyclopentan-1-ylsilanediol, in males at the high dose of 1000 mg/kg/day the relative weights of the liver and thyroid gland were increased by 17% and 20%, respectively, compared to the control, and in females at the high dose of 360 mg/kg/day the relative weights of the liver and thyroid gland were increased by 34% and 7%, respectively, compared to the control (MHLW, 2000) . For 4-methyl-2,4-diphenylpent-1-ene, in males, at the high dose of 720 mg/kg/day the relative weights of the liver and thyroid gland were obviously increased by 68% and 47%, respectively, compared to the control, and in females at the high dose of 720 mg/kg/day the relative weights of the liver and thyroid gland were increased by 57% and 32% compared to the control (MHLW, 2007b) . On the other hand, the increases in the relative thyroid weights due to several thioamides are larger than the increases in the relative liver weights, namely, the ratio of the relative thyroid weight to the control versus the relative liver weight to the control ranged from 1.4 to 8.5 for thioamides (Kawasaki et al., 1998; Yamasaki et al., 2002; MHLW, 2004) and from 0.8 to 1.15 for the above-men-tioned three chemicals (MHLW, 1997 (MHLW, , 2000 (MHLW, and 2007b .
Considering the overall relationship of the relative organ weight changes of the thyroid gland and liver, there is a possibility that hypertrophy of the thyroid follicular cells caused by AMT might have been due to induction of the drug metabolizing enzymes in the liver. The mechanism is generally considered to be that the thyroid gland is stimulated by the increased blood level of thyroid stimulating hormone secreted by the pituitary glands, when the negative feedback effect is reduced due to decreased blood thyroid hormone as a result of metabolic degradation via hepatic induction of UDP-glucuronyl transferase (Capen, 2008) . Although there is presently no direct evidence about this chemical, the contribution of induction of the drug-metabolizing enzyme in the liver is more likely the mechanism than the direct action on the thyroid glands in males. This speculation would be reasonably supported by very recent report for the mechanistic consideration of hypothyroidism induced by chemical substances (Yamada et al., 2013) . In case of females, there are two possibilfemales is different from that in males, or a direct action on the thyroid gland, because the relative weight of the thyroid gland in females was increased much more than the relative weight of the liver as mentioned above.
Histopathological changes of the pituitary glands were clearly observed in males but not females. Because all females conceived and gave birth in this study protocol, this experimental condition may be a reason for no pathological changes of pituitary glands in females. Anyhow, it might be sure that the mechanism of present hypothyroidism will be due to increased degradation of thyroid hormone, followed by high thyroid stimulating hormone secretion from pituitary glands. But the histopathological changes of pituitary glands were much less in rats treated with AMT than 2-mercaptobenzimidazole, one of thioamide derivatives (Kawasaki et al., 1998) . In both cases, the hypertrophy of pituitary glands comes from a drop of plasma thyroid hormone level.
Eosinophilic bodies and hyaline droplets were observed in the kidneys of males at 250 mg/kg/day. These 2u -globulin complex using immunochemical staining, indicating that it is et al., 2006). As another clear effect in repeated-dose toxicity, anemia was observed at 250 mg/kg/day in both sexes. It seems that the anemia is not based on a hemolytic mecha--es of the reticulocyte count ratio, extramedullary hematopoiesis or hemosiderin deposition. Vacuolization of the renal tubular epithelium and regenerative epithelium was found in 1/5, 4/6 and 3/12 females at 10, 50 and 250 mg/ kg/day, respectively. The renal changes in one female at 10 mg/kg/day were judged not to be caused by AMT. On the other hand, it could not be denied that renal changes in the 50 and 250 mg/kg/day groups were due to the effect of AMT, even though there was not a clear dose-dependent relationship. However, anemia in both sexes and renal changes in females in this study were at least not considered to be due to thyrotoxicity, because both toxicities were not reported as toxicity due to ATZ or several thioamides. Therefore, the cause of anemia and renal toxicity was unknown.
Three females in the 250 mg/kg/day group died on the gestation day 23. Those deaths were considered to be caused by AMT due to the height of frequency of occurrence because death in late gestation or during delivery is rarely observed in general. Perforation of the forestomach, necrosis of fundic mucosa of the glandular stomach, hypertrophy of cortex of the adrenals, vacuolization of tubular epithelium with regenerative epithelium of the kidneys, atrophy of the thymus and etc. were found in dead animals. These changes were historically noted in females which died in late gestation and dams whose all litter died after delivery. Therefore, this death was considered to be caused by overlapping the effect of administration and the stress just before delivery.
The reproduction and gestation periods were prolonged and the delivery index decreased at 250 mg/kg/day. An -tation loss was noted at 250 mg/kg/day, and as this secondary effect, the number of live pups born and the birth index also decreased. In a similar way, a prolonged gestation period and a decrease in the number of live births have been reported when the thyroid function is decreased the same happened in this study. However, the decreased thyroid function in the literature was achieved by thyroidectomy, a very severe condition, and the degree of reproductive toxicity is relatively lower than in the present case. Low levels of FSH and LH, and high levels of progesterone and prolactin were also reported as a possible effect of propylthiouracil or thyroidectomy (Hatsuta et al., 2004) on pregnancy. Although both treatment and surgery induced strong thyrotoxicity, the present study showed a very small increase in the relative weight of the thyroid glands. Therefore, the present reproductive toxicity is not considered to be due to decreased thyroid function, and the cause of these changes was unknown though there was a possibility of effects of anemia and renal toxicity.
In summary, the relative weights of the thyroid gland and liver were increased with hypertrophy of thyroid fol-licular cells and centrilobular hepatocytes in males and females. Vacuolization in the renal tubular epithelium was observed in females. As for reproduction, the gestation period was prolonged and the delivery index decreased. Based on these findings, it was concluded that 10 mg/ kg/day was the NOAEL based on the thyrotoxicity and renal toxicity for repeated-dose toxicity and the NOAEL was 50 mg/kg/day due to a reduced number of offspring, etc. for reproductive/developmental toxicity. The mechanism of hypothyroidism was considered that it may come from increased degradation of thyroid hormone by hepatic drug-metabolizing enzyme induction.
